YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
5.88
-0.27 (-4.39%)
Oct 7, 2026, 4:00 PM EDT - Market closed

YD Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
416857454750
Market Cap Growth
-67.46%1788.97%-4.31%-5.87%-
Enterprise Value
41485443--
Last Close Price
5.8812.1911.2511.0310.43

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
1362.13--3497.13-
PS Ratio
336.061436.2888.92135.44138.36
PB Ratio
93.11-300.176.892062.325396.83
P/TBV Ratio
208.22-11.612062.325396.83
P/FCF Ratio
----720.26
P/OCF Ratio
----720.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
333.921431.0783.59--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.000.000.002.0713.30
Debt / EBITDA Ratio
---1.186.81
Debt / FCF Ratio
----1.77
Net Debt / Equity Ratio
-0.592.10-0.47-1.7210.07
Net Debt / EBITDA Ratio
0.421.192.295.34-2.28
Net Debt / FCF Ratio
0.310.752.400.711.34
Asset Turnover
-0.060.141.28-
Inventory Turnover
-0.456.653.64-
Quick Ratio
2.703.9112.910.620.40
Current Ratio
5.235.8813.180.910.75
Return on Equity (ROE)
--445.10%-42.69%83.89%-
Return on Assets (ROA)
--31.92%-25.43%-2.25%-
Return on Invested Capital (ROIC)
-360.63%-67.52%-84.41%-17.44%-43.47%
Return on Capital Employed (ROCE)
-72.90%-43.40%-22.10%-42.80%-79.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
0.07%-0.97%-3.11%0.03%-0.10%
FCF Yield
-2.09%-0.94%-2.86%-0.12%0.14%
Buyback Yield / Dilution
13.49%-3.07%---
SEC Filings: 10-K · 10-Q